YuanBio Venture Capital
Venture capitalSuzhou · Seed–Growth · 9 people tracked
Find your way into YuanBio Venture Capital
1,061 people in our graph share verified history with the YuanBio Venture Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
YuanBio invests in highly innovative healthcare companies across China at early and growth stages while maintaining a global perspective on industry developments. Its focus spans biotech, medical devices, IVD and healthcare services. The firm leverages its base in Suzhou bioBay and close ties with the bioBay platform for high-quality deal flow, information exchange and post-investment support. Its team combines scientific expertise, industry experience and early-stage investment knowledge, supported by senior experts and consultants. YuanBio adds value through business development, management and operations, fundraising, and recruitment assistance, aiming to become one of China's most successful healthcare venture capital firms.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directories
What they invest in
from 14 of 75 portfolio companiesHealthtech ×12Biotech ×11Medical Devices ×11Digital Health ×5Hardware ×2Advanced Manufacturing ×1Deep Tech ×1Developer Tools ×1
HQs:China×11United States×2
Investments · 75 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 12021 · 13 dated
Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.
BiotechHealthtechMedical Devices
Samantha DuinSamantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)
Co-investorsQiming Venture PartnersVivo CapitalAdvantech CapitalKleiner PerkinsSequoia Capital
MacroLux Medical Technology develops endoscopic imaging systems and related medical devices.
HardwareHealthtechMedical DevicesShenzhen, CN
Co-investorsDalton VentureLegend CapitalB Capital GroupB4 Capital
.jpeg){kind=logo}
An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures Capital3H Health InvestmentSherpa Healthcare Partners
A pharmaceutical and life sciences company developing drug pipelines and conducting research and innovation activities.
BiotechHealthtechMedical DevicesShanghai, CN
Du JinhaoGuo Jianhui(Co-founder)
Co-investorsLAVLilly Asia Ventures
Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsDecheng CapitalQiming Venture Partners
Provider of R&D and one-stop production services to leading pharmaceutical companies worldwide.
Co-investorsHongShan Capital Group
A biopharmaceutical company developing CAR-T cell therapies for cancer treatment.
BiotechHealthtechMedical DevicesShanghai, CN
Co-investorsAcorn Pacific VenturesARCH Venture Partners
PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders.
BiotechHealthtechHangzhou, CN
Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.
BiotechDeep TechHardwareMedical Devices
Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in
Co-investorsForesite CapitalHighCape Capital
Shuwen Biotech develops molecular and immunodiagnostic products for women's health, including breast cancer subtyping kits, nucleic acid extraction systems, and point-of-care tests for pregnancy complications.
BiotechDigital HealthFemTechHealthtechMedical DevicesShanghai, CN
Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases.
BiotechHealthtechLongevityWaltham, US
Dr. Xiaodong Wang(Founder)Dr. Zhiyuan Zhang(Founder)
Co-investorsARCH Venture PartnersF-Prime CapitalCBC GroupEight Roads VenturesFuture InnovationGaorong Capital+5 more
TriApex provides contract research organization (CRO) services supporting pharmaceutical and biologics development, including preclinical studies, clinical trial design, regulatory strategy, and post-market safety monitoring.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesNanjing, CN
Co-investorsApricot Capital
Jiangsu Wanhe Technology Group is a custom software development service provider offering native app and mini-program development, e-commerce platform building, and high-end brand website design for business clients.
Developer ToolsE-commerceSaaSSuzhou, CN
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AIVFOAlltechAscentage PharmaATKCBasecare MedicalBeiGeneBeikang MedicalBestview LaserBGI Genomics (华大基因)BrightGeneCapitalbio TechnologyCF PharmTechCreative SciencesDami & XiaomiDeepCytoDymindEnzymasterFuture VisionGBSGenskeyH-BioHC SemiTekHengruiHengsheng MedicalHenlius BiotechiKangInnoModels BioInnoventiXINGJingfeng PharmaKangfu ZhijiaKangning HospitalKawin TechnologyKintor PharmaLegend CapitalLiferealLongwood ValleyNano-MicroNervtexNovaxelgenPanomixPharmacodiaPortenRainsureRongchang BioShengNuo BiotechSinobioway MedicineSINQISnibe DiagnosticSorrentoSunvouTigermedTongshu GeneUnionStrongUnited ImagingXABTXpeedic TechnologyYHLO BiotechZylox-Tonbridge
Exits · 3
3 IPOs · showing 2Adlai NortyeNASDAQ: ANLZai LabNASDAQ: ZLAB
Portfolio news
latest coverage across their companies
PegBio · finance.yahoo.com · Aug 28, 2026
Alebund · fiercebiotech.com · Aug 12, 2026
Zai Lab · simplywall.st · Aug 11, 2026
JW Therapeutics · tipranks.com · Jun 26, 2026
Frequently asked questions
- How many investments has YuanBio Venture Capital made?
- YuanBio Venture Capital has 75 tracked investments, 3 of which have exited, including 2 dated in the last 24 months.
- What stage does YuanBio Venture Capital invest at?
- YuanBio Venture Capital invests at the Seed, Series A, Series B, Growth stages.
- What is YuanBio Venture Capital's typical check size?
- YuanBio Venture Capital typically writes checks of $3M – $73M.
- What sectors does YuanBio Venture Capital focus on?
- YuanBio Venture Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is YuanBio Venture Capital located?
- YuanBio Venture Capital is headquartered in Suzhou, CN.
- Does YuanBio Venture Capital lead rounds?
- YuanBio Venture Capital typically participates in rounds rather than leading them.
- Who does YuanBio Venture Capital co-invest with?
- YuanBio Venture Capital most often shares deals with ARCH Venture Partners, Qiming Venture Partners, F-Prime Capital, among 10 tracked co-investors.
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.